Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Primary Progressive Multiple Sclerosis (PPMS) Market Overview 2017 - Research and Markets

Research and Markets
Posted on: 22 Dec 17

The "Primary Progressive Multiple Sclerosis (PPMS) - An Overview" report has been added to Research and Markets' offering.

The report provides an overview of primary progressive multiple sclerosis (PPMS) disease indication in detail. The report starts with the basic definition, causes and symptoms of Multiple Sclerosis and further details the types of Multiple Sclerosis disease indication. The report elaborates on the Primary Progressive Multiple Sclerosis disease indication starting from the definition and the causes of the PPMS indication.

The report covers further details on the profile of a PPMS patient, the symptoms of a PPMS patient, and disease progression in a PPMS patient. The report further highlights the multiple methods through which the patient can be diagnosed for PPMS.

Key Topics Covered:

1. Multiple Sclerosis Definition

2. Types of Multiple Sclerosis

a. Relapsing Remitting MS

b. Secondary Progressive MS

c. Primary Progressive MS

d. Progressive Relapsing MS

3. Primary Progressive Relapsing MS Defined

4. Causes of PPMS

5. Profile of PPMS Patient

6. Symptoms of PPMS

7. Disease progression and impact on QoL

8. Disease Diagnosis

a. Disease diagnosis through symptoms

b. Disease diagnosis through medical tests

For more information about this report visit

View source version on

Business Wire

Last updated on: 22/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.